20 May 2013
Keywords: vernalis, leaps, 400m, frova, deal, usa-based, endo
Article | 26 July 2004
USA-based Endo Pharmaceuticals says it has entered into a deal toacquire North American marketing rights for the migraine drug Frova
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 2004
24 May 2004
17 May 2013
© 2013 thepharmaletter.com